Thomson finalizes Solucient purchase

Share this article:
Thomson is buying the balance of Solucient from media giant VNU, private equity firm Veronis Suhler Stevenson and healthcare provider alliance VHA.

Thomson snapped up part of the informatics business—that focused on provision of services to payors—last February.

Now the Stamford-based firm has completed its acquisition of Solucient by picking up its analytics business directed at providers. Those businesses will be folded into Thomson's Medstat informatics unit.

Headquartered in Evanston, IL, Solucient boasts a staff of 500 and a secondary office in Ann Arbor, MI, where Medstat is based. Carol Diephuis, EVP at Thomson Medstat, said the firm might consider consolidating offices in the future, but for now, the companies are highly complementary.

“When you think about the combination of expertise and the massive market need in this space, there's growth opportunities for employees of both organizations,” she said. “Solucient helps round out our offering with a lot of information services for hospital managers as well as pharmaceutical companies.”

Before the acquisition, Thomson Health & Scientific employed 4,700. The firm has been moving away from medical publishing and more heavily into healthcare informatics since its divestiture of its Medical Economics business to Advanstar in October 2003.

Thomson continues to publish PDR. Other Thomson assets include its MercuryMD and Micromedix informatics businesses, aimed at healthcare providers, the CenterWatch suite of products and PDA program Clinical Xpert.

Share this article:

Email Newsletters

More in News

BMS Q2 sales slip, Eliquis, Yervoy soar

BMS Q2 sales slip, Eliquis, Yervoy soar

The company attributed part of the Eliquis boost to the BMS-Pfizer DTC and education efforts.

Gilead, Merck HCV marketing battle may be on horizon

Gilead, Merck HCV marketing battle may be on ...

Disclosed in its earnings report yesterday, Gilead may have a card up its sleeve to counter Merck's experimental hep. C combo regimen.

Sales of Biogen MS pill pick up overseas

Sales of Biogen MS pill pick up overseas

Biogen Idec is seeing strong sales for blockbuster MS drug Tecfidera, especially overseas where it's beginning to catch fire this summer.